| RS60617604 |
KRT5
|
Health Risk |
Likely pathogenic |
— |
| RS60618533 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Hypertrophic cardiomyopathy |
| RS606231119 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS606231120 |
GRXCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 25, Autosomal recessive nonsyndromic hearing loss 25 |
| RS606231121 |
ZFP57
|
Health Risk |
Pathogenic |
Diabetes mellitus, transient neonatal |
| RS606231122 |
ZFP57
|
Health Risk |
Pathogenic |
Diabetes mellitus, transient neonatal |
| RS606231123 |
ZFP57
|
Health Risk |
Pathogenic |
Diabetes mellitus, transient neonatal |
| RS606231125 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS606231126 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS606231127 |
STRA6
|
Health Risk |
Likely pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS606231128 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Congenital myasthenic syndrome |
| RS606231129 |
DOK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS606231130 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS606231131 |
DOK7
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS606231132 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS606231133 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS606231134 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS606231135 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS606231136 |
NSMF
|
Health Risk |
risk factor |
Hypogonadotropic hypogonadism 9 with or without anosmia, Hypogonadotropic hypogonadism 9 with or without anosmia |
| RS606231137 |
BBS9
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome |
| RS606231138 |
COQ8A
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS606231139 |
COQ8A
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS606231141 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary C1 esterase inhibitor deficiency - dysfunctional factor, Hereditary C1 esterase inhibitor deficiency - dysfunctional factor |
| RS606231146 |
LMBR1;ZRS
|
Health Risk |
Pathogenic |
Polydactyly of a triphalangeal thumb, Polydactyly of a triphalangeal thumb |
| RS606231147 |
ZRS
|
Health Risk |
Pathogenic |
Tibia, hypoplasia or aplasia of |
| RS606231148 |
LMBR1;ZRS
|
Health Risk |
Pathogenic |
Polydactyly of a triphalangeal thumb, Polydactyly of a triphalangeal thumb |
| RS606231149 |
LMBR1;ZRS
|
Health Risk |
Pathogenic |
Polydactyly of a triphalangeal thumb, Triphalangeal thumb |
| RS606231150 |
LMBR1;ZRS
|
Health Risk |
Pathogenic |
Polydactyly of a triphalangeal thumb, Triphalangeal thumb |
| RS606231151 |
LMBR1;ZRS
|
Health Risk |
Pathogenic |
Polydactyly of a triphalangeal thumb, Triphalangeal thumb |
| RS606231152 |
LMBR1;ZRS
|
Health Risk |
Pathogenic |
Polydactyly of a triphalangeal thumb, Triphalangeal thumb |
| RS606231154 |
SPINT2
|
Health Risk |
Pathogenic |
Congenital secretory sodium diarrhea 3, Congenital secretory sodium diarrhea 3 |
| RS606231155 |
SPINT2
|
Health Risk |
Pathogenic |
Congenital secretory sodium diarrhea 3, Congenital secretory sodium diarrhea 3 |
| RS606231157 |
SLC12A6
|
Health Risk |
Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Charcot-Marie-Tooth disease |
| RS606231158 |
SLC12A6
|
Health Risk |
Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Charcot-Marie-Tooth disease |
| RS606231159 |
LTBP4
|
Health Risk |
Pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS606231160 |
LTBP4
|
Health Risk |
Pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS606231161 |
LTBP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS606231162 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS606231163 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS606231164 |
DNAI1
|
Health Risk |
Pathogenic |
Kartagener syndrome, Kartagener syndrome |
| RS606231165 |
DNAI1
|
Health Risk |
Pathogenic |
Kartagener syndrome, Kartagener syndrome |
| RS606231166 |
ITM2B
|
Health Risk |
Pathogenic |
ADan amyloidosis, ADan amyloidosis |
| RS606231167 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Laurence-Moon syndrome |
| RS606231168 |
AGPAT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital generalized lipodystrophy type 1, Thyroid cancer |
| RS606231169 |
PTEN
|
Health Risk |
Likely pathogenic |
Prostate cancer, somatic |
| RS606231170 |
PTEN
|
Health Risk |
Pathogenic |
Prostate cancer, somatic |
| RS606231172 |
SLC16A1
|
Health Risk |
Pathogenic |
Exercise-induced hyperinsulinism, Exercise-induced hyperinsulinism |
| RS606231174 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysplasia 1, forme fruste |
| RS606231178 |
SRY
|
Health Risk |
Pathogenic |
46, XY sex reversal 1 |
| RS606231179 |
SRY
|
Health Risk |
Pathogenic |
46, XY sex reversal 1 |
| RS606231180 |
RPGR
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 1, Retinal dystrophy |
| RS606231181 |
RPGR
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 1, Retinal dystrophy |
| RS606231182 |
ZDHHC9
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Raymond type, Syndromic X-linked intellectual disability Raymond type |
| RS606231183 |
ZDHHC9
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Raymond type, Syndromic X-linked intellectual disability Raymond type |
| RS606231184 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS606231185 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS606231186 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS606231187 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS606231188 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS606231189 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Inborn genetic diseases |
| RS606231190 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS606231191 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS606231193 |
PQBP1
|
Health Risk |
Pathogenic |
Renpenning syndrome, PQBP1-related disorder |
| RS606231196 |
PQBP1
|
Health Risk |
Likely pathogenic |
Renpenning syndrome, Renpenning syndrome |
| RS606231197 |
PQBP1
|
Health Risk |
Pathogenic |
Renpenning syndrome, Renpenning syndrome |
| RS606231202 |
KRAS
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS606231203 |
EPCAM
|
Health Risk |
Pathogenic |
Congenital diarrhea 5 with tufting enteropathy, Gastric cancer |
| RS606231204 |
EPCAM
|
Health Risk |
Pathogenic |
Congenital diarrhea 5 with tufting enteropathy, EPCAM-related disorder |
| RS606231205 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS606231206 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS606231207 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS606231208 |
NR5A1
|
Health Risk |
Pathogenic |
Premature ovarian failure 7, Premature ovarian failure 7 |
| RS606231209 |
PDGFRA
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS606231210 |
PLG
|
Health Risk |
Pathogenic |
Plasminogen deficiency, type I |
| RS606231212 |
NEFH
|
Health Risk |
risk factor |
Amyotrophic lateral sclerosis, susceptibility to |
| RS606231214 |
KRT6A
|
Health Risk |
Pathogenic |
Pachyonychia congenita 3, Pachyonychia congenita 3 |
| RS606231220 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS606231221 |
GRN
|
Health Risk |
Likely pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS606231222 |
H6PD
|
Health Risk |
Pathogenic |
Cortisone reductase deficiency 1, Cortisone reductase deficiency 1 |
| RS606231223 |
FGB
|
Health Risk |
Pathogenic |
Congenital afibrinogenemia, Congenital afibrinogenemia |
| RS606231224 |
FGB
|
Health Risk |
Pathogenic |
Congenital afibrinogenemia, Congenital afibrinogenemia |
| RS606231225 |
FGA
|
Health Risk |
Pathogenic |
Congenital afibrinogenemia, Congenital afibrinogenemia |
| RS606231226 |
DPP6
|
Health Risk |
Pathogenic; risk factor |
Ventricular fibrillation, paroxysmal familial |
| RS606231228 |
BRAF
|
Health Risk |
Pathogenic |
Noonan syndrome 7, RASopathy |
| RS606231229 |
SLC12A6
|
Health Risk |
Pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Charcot-Marie-Tooth disease |
| RS606231230 |
ZRS
|
Health Risk |
Pathogenic |
Polydactyly of a triphalangeal thumb, Polydactyly of a triphalangeal thumb |
| RS606231231 |
ZRS
|
Health Risk |
Pathogenic |
Polydactyly of a triphalangeal thumb, Polydactyly of a triphalangeal thumb |
| RS606231233 |
KHDC3L
|
Health Risk |
Pathogenic |
Hydatidiform mole, recurrent |
| RS606231234 |
KHDC3L
|
Health Risk |
Pathogenic |
Hydatidiform mole, recurrent |
| RS606231236 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia |
| RS606231237 |
DHTKD1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2Q, Charcot-Marie-Tooth disease type 2A2 |
| RS606231238 |
ODAD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia 20, Primary ciliary dyskinesia |
| RS606231239 |
ODAD1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 20, Primary ciliary dyskinesia |
| RS606231240 |
ODAD1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 20, Adams-Oliver syndrome 5 |
| RS606231241 |
PAPSS2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, PAPSS2 type |
| RS606231242 |
PAPSS2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, PAPSS2 type |
| RS606231243 |
PAPSS2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, PAPSS2 type |
| RS606231246 |
CORO1A
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CORO1A deficiency, Severe combined immunodeficiency due to CORO1A deficiency |
| RS606231248 |
MRC1
|
Health Risk |
Uncertain risk allele; risk factor |
Susceptibility to leprosy and multibacillary leprosy, Leprosy |
| RS606231249 |
PNPLA6
|
Health Risk |
Pathogenic |
Ataxia-hypogonadism-choroidal dystrophy syndrome, Hereditary spastic paraplegia 39 |